I completly agree with your comment. Keep in mind that CP1 specialises in medical cannabis and its impact on animals and not individiuals, different segments of the MC industry. GLTAH
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025